SEC Form 4 · accession 0000921895-18-000526
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Kelton
Officer — Chief Executive Officer
Period of report
Feb 9, 2018
Accepted (ET)
Feb 12, 2018 · 8:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2018 | J | 85,003 | — | A | 93,176 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares issued to the Reporting Person by the Issuer as payment of an earn-out in connection with the Issuer's acquisition of a wholly-owned subsidiary in March 2017, of which the Reporting Person had been an employee and shareholder.